Lv1
30 积分 2022-06-11 加入
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
22小时前
待确认
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
22小时前
已完结
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
2天前
已完结
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
3天前
已完结
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
3天前
已完结
Melanocyte‐specific CD49a+CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy
4天前
已关闭
OX40L-expressing B cells promote SLE
7天前
已完结
Human skin-resident CD8+ T cells require RUNX2 and RUNX3 for induction of cytotoxicity and expression of the integrin CD49a
8天前
已完结
Sequential immunotherapy: towards cures for autoimmunity
8天前
已完结
Genetics and Epigenetics in Vitiligo
9天前
已完结
皖公网安备34019202002308
